Skip to content
South Korea
-
South Korean MedTech firm AdipoLABs opens Asia-Pacific Regional Office in Malaysia to drive healthcare innovation
AdipoLABs operates as a Ministry of Health (MOH)-registered medical device establishment under the Medical Device Authority (MDA), providing regulatory credibility and demonstrating commitment to quality and innovation.
-
SK Biopharmaceuticals expands oncology pipeline with US radiopharmaceutical deal.
WT-7695, a preclinical radiopharmaceutical targeting carbonic anhydrase IX (CA9), was developed in collaboration with the University of Wisconsin-Madison, and SK now holds exclusive worldwide rights to develop, manufacture, and market the drug.